RT Journal Article
SR Electronic
T1 638 Characterisation of the immune response to EO2401, a new immunotherapy approach against cancer, plus nivolumab in recurrent glioblastoma: The EOGBM1–18/ROSALIE study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A730
OP A730
DO 10.1136/jitc-2023-SITC2023.0638
VO 11
IS Suppl 1
A1 Maia, Ana
A1 Toussaint, Hélène
A1 Magalhaes, Joao Gamelas
A1 Idbaih, Ahmed
A1 Villar, Maria Vieito
A1 Tabatabai, Ghazaleh
A1 Stradella, Agostina
A1 Ghiringhelli, Francois
A1 Burger, Michael C
A1 Mildenberger, Iris
A1 Herrlinger, Ulrich
A1 González, Macarena
A1 Hervieu, Alice
A1 GilMartin, Marta
A1 Renovanz, Mirjam
A1 Touat, Mehdi
A1 Wen, Patrick
A1 Wick, Antje
A1 Bonny, Christophe
A1 Paillarse, Jean-Michel
A1 Reardon, David
A1 Wick, Wolfgang
A1 Gouttefangeas, Cécile
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A730.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.